SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Inrad Optics, Inc. – ‘10-Q’ for 9/30/19 – ‘EX-101.SCH’

On:  Thursday, 11/14/19, at 12:01pm ET   ·   For:  9/30/19   ·   Accession #:  1104659-19-63973   ·   File #:  0-11668

Previous ‘10-Q’:  ‘10-Q’ on 8/14/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/14/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/19  Inrad Optics, Inc.                10-Q        9/30/19   49:4.1M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    254K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     17K 
28: R1          Document and Entity Information                     HTML     47K 
48: R2          Condensed Consolidated Balance Sheets               HTML    107K 
38: R3          Condensed Consolidated Balance Sheets               HTML     29K 
                (Parenthetical)                                                  
20: R4          Condensed Consolidated Statements of Operations     HTML     67K 
29: R5          Condensed Consolidated Statements of Shareholders'  HTML     59K 
                Equity                                                           
49: R6          Condensed Consolidated Statements of Cash Flows     HTML     87K 
39: R7          Summary of Significant Accounting Policies          HTML    199K 
21: R8          Revenue                                             HTML     92K 
27: R9          Equity Compensation Program and Stock Based         HTML    132K 
                Compensation                                                     
45: R10         Stockholders' Equity                                HTML     19K 
33: R11         Related Party Transactions                          HTML     20K 
18: R12         Other Long Term Notes                               HTML     34K 
25: R13         Lease Amendment                                     HTML     45K 
46: R14         Summary of Significant Accounting Policies          HTML    228K 
                (Policies)                                                       
34: R15         Summary of Significant Accounting Policies          HTML    183K 
                (Tables)                                                         
19: R16         Revenue (Tables)                                    HTML     81K 
26: R17         Equity Compensation Program and Stock Based         HTML    139K 
                Compensation (Tables)                                            
44: R18         Other Long Term Notes (Tables)                      HTML     33K 
35: R19         Lease Amendment (Tables)                            HTML     45K 
13: R20         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     26K 
                Inventories (Details)                                            
31: R21         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic  HTML     75K 
                and diluted earnings (Loss) Per Common Share                     
                (Details)                                                        
42: R22         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     45K 
                Additional Information (Details)                                 
40: R23         Revenue (Details)                                   HTML     34K 
14: R24         Revenue - Additional Information (Details)          HTML     29K 
32: R25         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     26K 
                COMPENSATION - Share based compensation (Details)                
43: R26         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     27K 
                COMPENSATION - Stock Option Expense (Details)                    
41: R27         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     56K 
                COMPENSATION - Stock Option Activity (Details)                   
15: R28         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     33K 
                COMPENSATION - Non-vested stock option activity                  
                (Details)                                                        
30: R29         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     35K 
                COMPENSATION - Additional Information (Details)                  
24: R30         Stockholders' Equity (Details)                      HTML     20K 
17: R31         Related Party Transactions (Details)                HTML     39K 
36: R32         Other Long Term Notes (Details)                     HTML     24K 
47: R33         Other Long Term Notes - Additional Information      HTML     21K 
                (Details)                                                        
23: R34         LEASE AMENDMENT - Future minimum lease payments     HTML     38K 
                (Details)                                                        
16: R35         LEASE AMENDMENT - Additional information (Details)  HTML     24K 
37: XML         IDEA XML File -- Filing Summary                      XML     82K 
22: EXCEL       IDEA Workbook of Financial Reports                  XLSX     43K 
 6: EX-101.INS  XBRL Instance -- inrd-20190930                       XML   1.50M 
 8: EX-101.CAL  XBRL Calculations -- inrd-20190930_cal               XML     99K 
 9: EX-101.DEF  XBRL Definitions -- inrd-20190930_def                XML    155K 
10: EX-101.LAB  XBRL Labels -- inrd-20190930_lab                     XML    572K 
11: EX-101.PRE  XBRL Presentations -- inrd-20190930_pre              XML    444K 
 7: EX-101.SCH  XBRL Schema -- inrd-20190930                         XSD     80K 
12: ZIP         XBRL Zipped Folder -- 0001104659-19-063973-xbrl      Zip     85K

‘EX-101.SCH’   —   XBRL Schema — inrd-20190930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL document created with Toppan Merrill Bridge 9.4.0.81 -->
<!-- Based on XBRL 2.1 -->
<!-- Created on: 11/13/2019 12:39:48 PM -->
<!-- Modified on: 11/13/2019 12:39:48 PM -->
<schema xmlns:inrd="http://www.inradoptics.com/20190930" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns="http://www.w3.org/2001/XMLSchema" targetNamespace="http://www.inradoptics.com/20190930" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.inradoptics.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
<link:definition> 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/StatementCondensedConsolidatedStatementsOfOperations" id="StatementCondensedConsolidatedStatementsOfOperations">
<link:definition> 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows">
<link:definition> 00400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesInventoriesDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesInventoriesDetails">
<link:definition> 40101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureLeaseAmendmentFutureMinimumLeasePaymentsDetails" id="DisclosureLeaseAmendmentFutureMinimumLeasePaymentsDetails">
<link:definition> 40701 - Disclosure - LEASE AMENDMENT - Future minimum lease payments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureLeaseAmendmentFutureMinimumLeasePaymentsDetailsCalc2" id="DisclosureLeaseAmendmentFutureMinimumLeasePaymentsDetailsCalc2">
<link:definition> 40701 - Disclosure - LEASE AMENDMENT - Future minimum lease payments (Details) - calc 2 </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/StatementCondensedConsolidatedStatementsOfShareholdersEquity" id="StatementCondensedConsolidatedStatementsOfShareholdersEquity">
<link:definition> 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesBasicAndDilutedEarningsLossPerCommonShareDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesBasicAndDilutedEarningsLossPerCommonShareDetails">
<link:definition> 40102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and diluted earnings (loss) per common share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
<link:definition> 40103 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRevenueDetails" id="DisclosureRevenueDetails">
<link:definition> 40201 - Disclosure - REVENUE (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRevenueAdditionalInformationDetails" id="DisclosureRevenueAdditionalInformationDetails">
<link:definition> 40202 - Disclosure - REVENUE - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationShareBasedCompensationDetails" id="DisclosureEquityCompensationProgramAndStockBasedCompensationShareBasedCompensationDetails">
<link:definition> 40301 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION - Share based compensation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationStockOptionExpenseDetails" id="DisclosureEquityCompensationProgramAndStockBasedCompensationStockOptionExpenseDetails">
<link:definition> 40302 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION - Stock Option Expense (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationStockOptionActivityDetails" id="DisclosureEquityCompensationProgramAndStockBasedCompensationStockOptionActivityDetails">
<link:definition> 40303 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION - Stock Option Activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationNonVestedStockOptionActivityDetails" id="DisclosureEquityCompensationProgramAndStockBasedCompensationNonVestedStockOptionActivityDetails">
<link:definition> 40304 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION - Non-vested stock option activity (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationAdditionalInformationDetails" id="DisclosureEquityCompensationProgramAndStockBasedCompensationAdditionalInformationDetails">
<link:definition> 40305 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureStockholdersEquityDetails" id="DisclosureStockholdersEquityDetails">
<link:definition> 40401 - Disclosure - STOCKHOLDERS' EQUITY (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRelatedPartyTransactionsDetails" id="DisclosureRelatedPartyTransactionsDetails">
<link:definition> 40501 - Disclosure - RELATED PARTY TRANSACTIONS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureOtherLongTermNotesDetails" id="DisclosureOtherLongTermNotesDetails">
<link:definition> 40601 - Disclosure - OTHER LONG TERM NOTES (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureOtherLongTermNotesAdditionalInformationDetails" id="DisclosureOtherLongTermNotesAdditionalInformationDetails">
<link:definition> 40602 - Disclosure - OTHER LONG TERM NOTES - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureLeaseAmendmentAdditionalInformationDetails" id="DisclosureLeaseAmendmentAdditionalInformationDetails">
<link:definition> 40702 - Disclosure - LEASE AMENDMENT - Additional information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
<link:definition> 00090 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPolicies" id="DisclosureSummaryOfSignificantAccountingPolicies">
<link:definition> 10101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRevenue" id="DisclosureRevenue">
<link:definition> 10201 - Disclosure - REVENUE </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensation" id="DisclosureEquityCompensationProgramAndStockBasedCompensation">
<link:definition> 10301 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
<link:definition> 10401 - Disclosure - STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRelatedPartyTransactions" id="DisclosureRelatedPartyTransactions">
<link:definition> 10501 - Disclosure - RELATED PARTY TRANSACTIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureOtherLongTermNotes" id="DisclosureOtherLongTermNotes">
<link:definition> 10601 - Disclosure - OTHER LONG TERM NOTES </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureLeaseAmendment" id="DisclosureLeaseAmendment">
<link:definition> 10701 - Disclosure - LEASE AMENDMENT </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 20102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
<link:definition> 30103 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureRevenueTables" id="DisclosureRevenueTables">
<link:definition> 30203 - Disclosure - REVENUE (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureEquityCompensationProgramAndStockBasedCompensationTables" id="DisclosureEquityCompensationProgramAndStockBasedCompensationTables">
<link:definition> 30303 - Disclosure - EQUITY COMPENSATION PROGRAM AND STOCK BASED COMPENSATION (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureOtherLongTermNotesTables" id="DisclosureOtherLongTermNotesTables">
<link:definition> 30603 - Disclosure - OTHER LONG TERM NOTES (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.inradoptics.com/role/DisclosureLeaseAmendmentTables" id="DisclosureLeaseAmendmentTables">
<link:definition> 30703 - Disclosure - LEASE AMENDMENT (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="inrd-20190930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="inrd-20190930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="inrd-20190930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="inrd-20190930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd"/>
<import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_DocumentAndEntityInformationAbstract" substitutionGroup="xbrli:item"/>
<element name="CapitalInExcessOfParValueMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_CapitalInExcessOfParValueMember" substitutionGroup="xbrli:item"/>
<element name="AccumulatedDeficitMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_AccumulatedDeficitMember" substitutionGroup="xbrli:item"/>
<element id="inrd_ScheduleOfReconciliationOfSharesUsedInCalculationOfBasicAndDilutedEarningsPerCommonShareTableTextBlock" name="ScheduleOfReconciliationOfSharesUsedInCalculationOfBasicAndDilutedEarningsPerCommonShareTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedTableTextBlock" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonVestedTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element name="DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveAccruedInterestOnConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="inrd_DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveAccruedInterestOnConvertibleNotes" substitutionGroup="xbrli:item" xbrli:balance="credit"/>
<element name="DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="inrd_DilutiveSecuritiesEffectOnBasicEarningsPerShareDilutiveWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit"/>
<element name="IncrementalCommonSharesAttributableToDilutiveEffectOfAccruedInterestOnConvertibleNotes" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="inrd_IncrementalCommonSharesAttributableToDilutiveEffectOfAccruedInterestOnConvertibleNotes" substitutionGroup="xbrli:item"/>
<element name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_SummaryOfSignificantAccountingPoliciesTable" substitutionGroup="xbrldt:hypercubeItem"/>
<element name="SellingExpenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_SellingExpenseMember" substitutionGroup="xbrli:item"/>
<element name="NatureOfBusinessAndOperationsAndSummaryOfSignificantAccountingPoliciesAndEstimatesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_NatureOfBusinessAndOperationsAndSummaryOfSignificantAccountingPoliciesAndEstimatesLineItems" substitutionGroup="xbrli:item"/>
<element name="AerospaceDefenseMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_AerospaceDefenseMember" substitutionGroup="xbrli:item"/>
<element name="ProcessControlMetrologyMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_ProcessControlMetrologyMember" substitutionGroup="xbrli:item"/>
<element name="LaserSystemsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_LaserSystemsMember" substitutionGroup="xbrli:item"/>
<element name="ScientificRdMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_ScientificRdMember" substitutionGroup="xbrli:item"/>
<element name="PercentageOfRevenueFromProductsOrServices" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="inrd_PercentageOfRevenueFromProductsOrServices" substitutionGroup="xbrli:item"/>
<element name="ClarexMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_ClarexMember" substitutionGroup="xbrli:item"/>
<element name="AffiliateOfClarexMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="inrd_AffiliateOfClarexMember" substitutionGroup="xbrli:item"/>
<element name="WarrantsToPurchaseCommonStockNumberOfSharesPerWarrant" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="inrd_WarrantsToPurchaseCommonStockNumberOfSharesPerWarrant" substitutionGroup="xbrli:item"/>
<element id="inrd_EarningsPerShareDilutedConversionNotes" name="EarningsPerShareDilutedConversionNotes" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_EarningsPerShareDilutedAccruedInterestOnConvertibleNotes" name="EarningsPerShareDilutedAccruedInterestOnConvertibleNotes" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_EarningsPerShareDilutedWarrants" name="EarningsPerShareDilutedWarrants" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_EarningsPerShareDilutedStockOptions" name="EarningsPerShareDilutedStockOptions" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_LesseeOperatingLeaseOtherInformationTableTextBlock" name="LesseeOperatingLeaseOtherInformationTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
<element id="inrd_InvestmentWarrantsExercisePrice1" name="InvestmentWarrantsExercisePrice1" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"/>
</schema>

↑Top
Filing Submission 0001104659-19-063973   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 8:45:25.1pm ET